BioCentury
ARTICLE | Politics & Policy

NIH seeks to trim gene therapy review, turn oversight to newer tech

August 16, 2018 9:28 PM UTC

NIH wants to scrap Recombinant DNA Advisory Committee (RAC) review for gene therapy protocols in a move that will reduce redundant oversight while allowing RAC to advise on newer innovations.

NIH established RAC in 1974 to provide increased oversight of and a public forum to discuss recombinant DNA and gene transfer research. The committee provides recommendations to the NIH director on basic and clinical research involving recombinant or synthetic nucleic acid molecules...